Science
Race to Develop Ebola Vaccine
Moderna and other companies are racing to develop an mRNA vaccine for the Bundibugyo strain of Ebola, which is currently driving a major outbreak. The urgency underscores the global health threat posed by this rare virus.
Coverage timeline — 1 article
Scientific American
As Ebola rages, Moderna and others are racing to develop an mRNA vaccine for the rare Bundibugyo virus driving the current outbreak
2026-06-14 11:00 UTC